Supplemental Table 3. Factors associated with the primary composite outcome in the low LDL-C group.
| Variables | Univariate analysis | ||
|---|---|---|---|
| HR | 95% CI | p-value | |
| Age, years | 1.06 | 1.03-1.09 | 0.0001 |
| Male | 0.60 | 0.30-1.20 | 0.15 |
| Body mass index, per 1 kg/m² | 0.96 | 0.88-1.04 | 0.30 |
| Hypertension | 0.71 | 0.40-1.26 | 0.25 |
| Diabetes mellitus | 1.09 | 0.61-1.93 | 0.77 |
| Current smoker | 0.98 | 0.55-1.72 | 0.93 |
| History of MI | 2.10 | 0.65-6.79 | 0.21 |
| With cancer | 0.93 | 0.23-3.84 | 0.92 |
| eGFR on admission, per 10 mL/min/1.73m² | 0.90 | 0.77-1.05 | 0.20 |
| HDL-C on admission, per 10 mg/dL | 0.97 | 0.78-1.17 | 0.77 |
| LDL-C on admission, per 10 mg/dL | 0.99 | 0.98-1.02 | 0.96 |
| LDL-C after discharge (1 month), per 10 mg/dL | 0.95 | 0.80-1.11 | 0.52 |
| Reduction in LDL-C levels after discharge (1 month), per 10 mg/dL | 1.06 | 0.93-1.21 | 0.40 |
| TG on admission, per 10 mg/dL | 0.98 | 0.95-1.00 | 0.11 |
| BNP on admission, per 100 pg/mL | 1.09 | 0.96-1.21 | 0.12 |
| hs-CRP ≥ 0.2 mg/dL on admission | 1.01 | 0.57-1.78 | 0.98 |
| hs-CRP ≥ 0.2 mg/dL in the chronic phase | 1.92 | 1.07-3.46 | 0.03 |
| GNRI ＜92 | 1.14 | 0.48-2.69 | 0.77 |
| LVEF on admission, per 10% | 0.82 | 0.66-1.03 | 0.09 |
| STEMI | 1.73 | 0.88-3.40 | 0.11 |
| Multivessel disease | 1.79 | 0.99-3.21 | 0.05 |
| Medication at discharge | |||
| align="center"Beta blocker | 1.17 | 0.66-2.10 | 0.59 |
| ACE-I or ARB | 1.02 | 0.50-2.04 | 0.96 |
| Strong statin | 0.73 | 0.36-1.46 | 0.37 |
| Gait speed, per 0.1 m/s | 0.81 | 0.71-0.93 | 0.002 |
| Ln RHI, per 0.1 | 0.83 | 0.73-0.94 | 0.003 |
ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; BNP, B- type natriuretic peptide; eGFR, estimated glomerular filtration rate; GNRI, geriatric nutritional risk index; HDL-C, high-density lipoprotein cholesterol; hs-CRP, high-sensitivity C-reactive protein; LDL-C, low-density lipoprotein cholesterol; Ln RHI, logarithmic value of reactive hyperemia index; LVEF, left ventricular ejection fraction; MI, myocardial infarction; STEMI, ST-segment elevation myocardial infarction; TG, triglycerides.